Brittany Roy

Manager, Epidemiology
Alkermes

Alkermes (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Poster(s):

• (P-312) Disease Prevalence, Comorbidities, and Medication Utilization Among Patients with Opioid Use Disorder in the US

• (P-313) Utilizing a Structured Benefit-risk Assessment to Evaluate a Combination of Olanzapine and Samidorphan for the Treatment of Schizophrenia and Bipolar I Disorder